AWM
CLX icon

Abound Wealth Management’s Clorox CLX Stock Holding History

Abound Wealth Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42K Sell
36
-16
-31% -$1.54K ﹤0.01% 663
2026
Q1 		$5.37K Hold
52
– – ﹤0.01% 711
2025
Q4 		$5.23K Sell
52
-1
-2% -$109 ﹤0.01% 659
2025
Q3 		$6.5K Buy
53
+1
+2% +$124 ﹤0.01% 582
2025
Q2 		$6.23K Sell
52
-14
-21% -$1.87K ﹤0.01% 529
2025
Q1 		$9.7K Sell
66
-11
-14% -$1.68K ﹤0.01% 406
2024
Q4 		$12.5K Buy
77
+4
+5% +$654 ﹤0.01% 356
2024
Q3 		$11.9K Buy
73
+12
+20% +$1.78K ﹤0.01% 386
2024
Q2 		$8.3K Sell
61
-9
-13% -$1.25K ﹤0.01% 399
2024
Q1 		$10.7K Sell
70
-75
-52% -$11.2K ﹤0.01% 357
2023
Q4 		$20.6K Buy
145
+75
+107% +$10K 0.01% 251
2023
Q3 		$9.17K Buy
70
+2
+3% +$304 ﹤0.01% 345
2023
Q2 		$10.8K Buy
68
+16
+31% +$2.58K ﹤0.01% 321
2023
Q1 		$8.17K Buy
52
+1
+2% +$150 ﹤0.01% 313
2022
Q4 		$7.2K Buy
51
+11
+28% +$1.56K ﹤0.01% 305
2022
Q3 		$5.14K Buy
+40
New +$5.77K ﹤0.01% 361

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Abound Wealth Management's CLX Position: Q2 2026 in Review

Abound Wealth Management reduced its Clorox (CLX) stake by 31% in Q2 2026, selling an estimated $1.54K and leaving 36 shares worth $3.42K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Abound Wealth Management first reported a position in CLX in Q3 2022 and has held it in 16 quarters since. The position peaked at $20.6K in Q4 2023. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Abound Wealth Management held 36 shares of Clorox worth $3.42K as of Q2 2026.
  • Abound Wealth Management sold 16 Clorox shares in Q2 2026, an estimated $1.54K.
  • Clorox made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #663 holding.
  • Abound Wealth Management first reported a position in Clorox in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Clorox position peaked at $20.6K in Q4 2023.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.